News - Appointments

Nosopharm SAS of France has appointed Jacques Biton and Frédéric Hammel to its supervisory board as it rolls out plans for its pipeline of antimicrobial molecules. Dr Biton is a consultant with Novagreen Conseil, a specialist service company.

Valneva SE has appointed two leading vaccine experts to its scientific advisory board as it continues development of candidate vaccines against Lyme disease and chikungunya.

Vectura Group Plc has appointed Will Downie as its new chief executive as it advances a strategy to become a global player in the inhaled drug delivery services business.

Dario Eklund has been appointed chief executive of Switzerland-based Santhera Pharmaceuticals to lead its transition into a company with new commercial products.

UK-based Actimed Therapeutics Ltd has appointed Robin Bhattacherjee as chief executive to help the company drive development of its lead product for cancer-related cachexia.

ADC Therapeutics SA, developer of antibody-drug conjugates (ADCs), has appointed Jennifer Herron to the newly created position of chief commercial officer as the company  plans for a US regulatory submission of its lead product for diffuse large B cell lymphoma

Industry veteran Howard Mayer is to join Ipsen SA on 1 December as head of research and development to help oversee the French company’s business strategy. Dr Mayer will be based in Cambridge, Mass, US, and report directly to David Meek, the chief executive.

The investment group Abingworth LLP has appointed Neil Cooper as chief financial officer, based in London, UK, to manage its finance and business activities across the firm’s UK and US locations and support fundraising and investment activities.

Jean-Christophe May has been appointed chief commercial officer at Bavarian Nordic A/S, effective January 2020, where he will help the Denmark-based company commercialise its vaccines against infectious diseases and cancer.

James Clark, who has experience commercialising diagnostic and therapeutic products, has joined PredictImmune Ltd as chief technology officer where he will help oversee development of a test for inflammatory bowel disease.